Illustrative image – not actual.Chennai-based bulk drugs manufacturer, Orchid Chemicals & Pharmaceuticals Ltd, is planning to set up an overseas joint venture with Istituto Biochimico Pavese Pharma Spa of Italy.
The venture would focus on the development of novel peptide drugs, biotechnology products, innovative antioxidants and novel drug delivery systems that have attractive commercialisation plans.
The company is also mulling over the possibility of setting up a manufacturing and marketing joint venture in China, the largest market for anti-infectives. The proposed JV in China would also tap the potential of the Chinese formulations market.
The company’s other initiatives include a new research and development centre and an animal house-cum-toxicology centre. Orchid is building a new bulk active and formulations plant in Tamil Nadu, in order to explore regulated markets. The plant would be compliant with US Food and Drugs Administration (FDA) stipulations. Orchid is also investing in biotech products.
